Jump to content

Property:Results after intervention

From CAMIH

This is a property of type Text.

Showing 20 pages using this property.
R
S
Overall: Number in % Intervention: 100, Control: 96; p = 0.8 Mittelwert (SD): Intervention: 6.37 (2.85), Control: 6.57 (2.94); p = 0.78 No significant group differences were found when considering gender and age (no numbers reported).  +
''Intensity of nausea'' No significant difference between arms (p=0.238) ''Frequency of nausea'' Significant effects for ginger arm (p=0.013): - significant difference between ginger and chamomile arm (mean (SD): 1.66 (0.53); p=0.002) and ginger and control arm (mean (SD): 1.58 (0.58); p=0.006), no direction indicated - no significant difference between chamomile and control arm (p=0.895) ''Frequency of vomiting'' Significant effects for ginger and chamomile arm respectivly (p<0.0001; p=0.02) - significant differences between ginger and control (p>0.0001) and chamomile and control (p=0.003), no direction indicated - no significant difference between ginger and chamomile arm (p=0.177)  +
Median follow-up times were 33 month (3.8-79 month) for the intervention arm and 18.6 month (3-79 month) for the placebo arm: the 1-, 3- and 5-year overall survival percentages were not significantly different  +
Six months after study termination, a total of 312 deaths (32.7%) had occurred: 138 (29.0%) in the control arm and 174 (36.5%) in intervention arm; primary cause of death was prostate cancer in 108 participants (78.3%) in control arm and 142 (81.6%) in intervention arm, median overall survival was 20.2 months (95% CI, 18.8 to 23.0) in control arm and 17.8 months (95% CI, 16.0 to 19.5) in intervention arm, survival rate was significantly lower in the intervention arm (p = .002)  +
Mean (SD) Baseline - 3 months after chemotherapy N. tibialis and N. peroneus: No significant differences in amplitude, latency, and conduction velocity (p > 0.05) N. suralis: Amplitude: Intervention: 5.5 (2.4), Placebo: 3.82 (1.8); p < 0.01, sign. Latency, conduction velocity: ns.  +